Cargando…
Alternative splicing in endothelial cells: novel therapeutic opportunities in cancer angiogenesis
Alternative splicing (AS) is a pervasive molecular process generating multiple protein isoforms, from a single gene. It plays fundamental roles during development, differentiation and maintenance of tissue homeostasis, while aberrant AS is considered a hallmark of multiple diseases, including cancer...
Autores principales: | Di Matteo, Anna, Belloni, Elisa, Pradella, Davide, Cappelletto, Ambra, Volf, Nina, Zacchigna, Serena, Ghigna, Claudia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7720527/ https://www.ncbi.nlm.nih.gov/pubmed/33287867 http://dx.doi.org/10.1186/s13046-020-01753-1 |
Ejemplares similares
-
Gene Expression Profiles Controlled by the Alternative Splicing Factor Nova2 in Endothelial Cells
por: Belloni, Elisa, et al.
Publicado: (2019) -
A ligand-insensitive UNC5B splicing isoform regulates angiogenesis by promoting apoptosis
por: Pradella, Davide, et al.
Publicado: (2021) -
EMT and stemness: flexible processes tuned by alternative splicing in development and cancer progression
por: Pradella, Davide, et al.
Publicado: (2017) -
Alternative Splicing Changes Promoted by NOVA2 Upregulation in Endothelial Cells and Relevance for Gastric Cancer
por: Di Matteo, Anna, et al.
Publicado: (2023) -
Cardiac revascularization: state of the art and perspectives
por: Cappelletto, Ambra, et al.
Publicado: (2019)